Suspension of trading
Sector Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
|
Delayed
Nasdaq
01:30:00 18/05/2024 am IST
|
5-day change | 1st Jan Change | ||
| 15.13 USD | -0.13% |
|
-.--% | - |
| 21/24/21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
| 21/24/21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.13% | -.--% | -.--% | -.--% | -.--% | -.--% | +23.61% | +226.78% | -67.74% | 22Cr | |
| +0.11% | +2.71% | -3.57% | +10.98% | +1.45% | +0.33% | +28.59% | -27.10% | +198.14% | 4.62TCr | |
| -0.91% | +1.90% | +11.13% | +58.99% | +18.33% | +40.24% | +27.41% | +5.36% | +244.71% | 4.43TCr | |
| -3.59% | -6.39% | -11.69% | +17.03% | +139.49% | +321.83% | +516.72% | +522.96% | - | 4.22TCr | |
| -0.94% | +0.99% | -5.21% | +29.53% | +15.18% | +2.05% | +67.50% | -12.19% | +1,032.81% | 4.02TCr | |
| -0.50% | -0.77% | -10.75% | +2.75% | +4.07% | +11.86% | +40.41% | -20.80% | +135.95% | 2.98TCr | |
| -0.83% | +3.87% | +3.38% | +32.61% | +8.66% | +21.58% | +123.46% | +234.31% | +1,896.32% | 1.72TCr | |
| +0.17% | -9.18% | -3.83% | +3.68% | - | - | - | - | - | 1.57TCr | |
| -0.57% | +8.12% | +9.73% | +21.56% | +22.50% | +22.15% | +38.93% | -38.62% | +95.97% | 1.53TCr | |
| -4.00% | -3.76% | -2.45% | +11.61% | -10.58% | -9.18% | -38.05% | -39.36% | +116.66% | 1.31TCr | |
| -1.83% | -0.67% | -1.00% | +49.41% | +38.56% | +76.07% | +31.27% | -36.17% | +243.49% | 1.34TCr | |
| -3.58% | +31.72% | +57.48% | +52.89% | +31.63% | -10.73% | - | - | - | 1.45TCr | |
| -0.03% | +0.35% | +0.21% | +24.91% | +23.07% | +36.58% | +1.69% | -45.26% | +164.77% | 1.14TCr | |
| -1.03% | +4.21% | -13.59% | +95.31% | +52.30% | +22.01% | +50.77% | -55.92% | - | 1.1TCr | |
| -1.29% | +1.82% | -3.56% | +29.44% | +50.44% | +128.80% | +513.17% | +93.51% | - | 985.17Cr | |
| -0.21% | -3.27% | -8.90% | +27.00% | +64.11% | +130.66% | +712.07% | +1,006.80% | +849.21% | 929.86Cr | |
| -2.88% | -10.17% | -11.56% | +5.57% | -24.42% | +30.19% | +456.23% | +186.16% | +911.11% | 937.65Cr | |
| +5.70% | +22.94% | +50.84% | +249.07% | +216.75% | +131.41% | +102.37% | +16.74% | +1,454.94% | 1.08TCr | |
| -1.69% | +2.92% | +3.36% | +18.38% | -7.60% | -9.15% | -3.41% | -28.36% | +44.25% | 917.78Cr | |
| -3.41% | -9.95% | -18.54% | +6.72% | +2.22% | +566.13% | +1,314.51% | +8.16% | - | 866.83Cr | |
| Average | -1.03% | +2.96% | +2.07% | +37.37% | +34.01% | +79.62% | +222.62% | +110.94% | +522.90% | 1.86TCr | |
| Weighted average by Cap. | -1.11% | +2.85% | +0.77% | +33.59% | +36.03% | +75.69% | +175.42% | +97.57% | +514.56% |
- Stock Market
- Stocks
- MACK Stock
- Sector Merrimack Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
